ClinConnect ClinConnect Logo
Search / Trial NCT06201299

Chair-based and Standard Exercise Programs in People With COPD

Launched by ISTANBUL MEDIPOL UNIVERSITY HOSPITAL · Dec 30, 2023

Trial Information

Current as of June 27, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying the effects of two different exercise programs for people with Chronic Obstructive Pulmonary Disease (COPD). Participants will be divided into two groups: one will do a standard exercise program, while the other will focus on chair-based exercises, which are designed for those who may have difficulty with more intense physical activities. The goal is to see which type of exercise helps improve their health and well-being over an 8-week period, with exercises happening five days a week.

To be eligible for the trial, participants need to be between 18 and 75 years old, have a confirmed diagnosis of COPD, and experience shortness of breath when doing activities. They should also be in stable health without recent infections. Participants will start their training at the hospital and then continue at home using videos. They will receive support through online exercise sessions with a physiotherapist and weekly phone check-ins to help them stay on track. This trial aims to find effective ways to support people with COPD in improving their lung health through exercise.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being between the ages of 18-75 years
  • Having a diagnosis of COPD diagnosed according to clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS).
  • Presence of dyspnea on exertion
  • Stable clinical status at inclusion without infection or exacerbation in the previous 4 weeks \*Having smart phone usage skills
  • Exclusion Criteria:
  • Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and requiring high-flow oxygen therapy (˃ 3-4 L\\min).
  • A history of exertional syncope or the presence of any comorbidities (such as severe orthopedic or neurological deficits or unstable heart disease) that preclude exercise training.
  • Having participated in a pulmonary rehabilitation program within the last 12 months.

About Istanbul Medipol University Hospital

Istanbul Medipol University Hospital is a leading healthcare institution in Turkey, renowned for its commitment to advanced medical research and clinical excellence. As a prominent sponsor of clinical trials, the hospital leverages its state-of-the-art facilities and a multidisciplinary team of experts to facilitate innovative studies across various medical fields. With a strong emphasis on patient safety and ethical standards, Istanbul Medipol University Hospital strives to contribute to the advancement of medical knowledge and the development of effective treatments, ensuring high-quality care and improved health outcomes for patients.

Locations

Istanbul, Zeytinburnu, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported